Ginseng for Chronic Obstructive Pulmonary Disease: Study Protocol
Author Information
Author(s): Xue Charlie C, Shergis Johannah L, Zhang Anthony L, Worsnop Christopher, Fong Harry, Story David, Da Costa Cliff, Thien Francis CK
Primary Institution: RMIT University
Hypothesis
Does a standardised extract of ginseng produce beneficial effects/symptomatic relief in subjects with moderate COPD?
Conclusion
The study aims to evaluate the therapeutic value and safety of ginseng for improving quality of life in COPD patients.
Supporting Evidence
- Ginseng has been used for thousands of years in Chinese medicine for respiratory symptoms.
- Previous studies showed promising effects of ginseng on COPD but were limited by small sample sizes.
- This study aims to provide high-quality evidence on the effectiveness of ginseng for COPD.
Takeaway
This study is testing if ginseng can help people with breathing problems feel better and live better lives.
Methodology
A randomised, multi-centre, double-blind, placebo-controlled trial comparing ginseng extract to placebo over 24 weeks.
Potential Biases
Potential biases may arise from the self-reported nature of some outcomes and the exclusion of certain populations.
Limitations
The study may have limitations related to participant adherence and the generalizability of results.
Participant Demographics
Participants are aged 40 to 80 years, ex-smokers, and diagnosed with moderate COPD.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website